FDA
-
-
-
-
-
-
-
Inari Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Inari Medical Announces Three New Data Sets to be Presented During Late-Breaking Clinical Trial Sessions at the 2022 TCT and VEINS Conferences
-
-
-
-
-
-
-
OKAMI MEDICAL ANNOUNCES FDA 510(k) CLEARANCE OF THE LOBO-7 and LOBO-9 VASCULAR OCCLUDERS TO ADDRESS A WIDE RANGE OF PERIPHERAL EMBOLIZATION CASES
-
-
-
-
-
-
-
Inari Medical Announces Pricing of Offering of Common Stock
-
-
-
-
-
-
-
Inari Medical to Announce Fourth Quarter and Full-Year 2021 Financial Results
-
-
-
-
-
-
-
Inari Medical Announces 6-month FLASH Registry Interim Data Demonstrating Benefits of Lytic-Free Mechanical Thrombectomy in 500 Real-World PE Patients
-
-
-
-
-
-
-
Inari Medical Reports Second Quarter 2021 Financial ResultsĀ
-
251,895 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All